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We have made use ofT cell receptor (TCtk)-transgenic mice with CD4 + T  cells expressing a 
receptor specific for the self-antigen C5 (fifth component of complement) to study the role of 
different antigen-presenting cells in the determination ofCD4 + T  cell effector type. Contact of 
T  cells from C5 TCK-transgenic mice with C5 protein or C5 peptide in vivo or in vitro in- 
duces biased T  helper cell (Th) 1 type responses resulting in exclusive production of high levels 
of interferon ~/  and interleukin  (IL)  2.  Transgenic  mice, in  contrast to  nontransgenic  htter- 
mates, do not generate an antibody response to C5. We show in this paper that B cell presenta- 
tion in vitro induces a switch to the Th2 subset indicated by production of IL-4, and targetting 
C5 to B cells in vivo results in the generation of C5-specific antibodies. 
ctivation of CD4 + T  cells leads to their differentiation 
nto  subsets  that  are  characterized  by their  function 
and lymphokine secretion pattern.  Thl  cells  secrete  IL-2, 
IFN-~/, and TNF-I3, which are involved in macrophage acti- 
vation and  induction  of delayed-type hypersensitivity re- 
sponses.  The  lymphokines typical for Th2  cells  are  IL-4, 
IL-5, and IL-10 and are critical for IgG1 and IgE antibody 
production  (1).  These two T  cell subpopulations  regulate 
each  others'  function  through  the  antagonistic  activity of 
their respective cytokines (2, 3). Th lineage commitment is 
of crucial importance with respect to susceptibility or resis- 
tance  to  particular  infections  or  autoimmune  diseases.  A 
number of factors determine whether an immune response 
will be dominated by Thl or Th2 cells: cytokines acting in 
the microenvironment, and to some extent contributed by 
the innate  immune system, play an important role in hn- 
eage  differentiation.  IL-12 secretion by macrophages and 
dendritic  cells  drives  differentiation  of Thl  effector cells 
(4-6), and IL-4, which can be T  cell derived or secreted by 
CD4 + NK-like cells or basophils, drives Th2 development 
(7-13). 
However, the cytokine environment is not the only pa- 
rameter to regulate  the  differentiation  of CD4  T  cells.  A 
host  of recently published  data  has implicated  differential 
regulation  through  costimulatory molecules  (14,  15),  the 
effect ofhgand density (16),  and variations in signaling (17, 
18)  as instrumental in driving the commitment of CD4 T 
cells to either Thl or Th2. 
The use of TCR. transgenic mice has made it possible to 
investigate the switching of Th phenotype within a mono- 
clonal T  cell population and has provided compelling evi- 
dence for the  crucial  role  of IL-12 in Thl  differentiation 
(3). We have made use of another TCR transgenic mouse 
system with CD4 + T  cells expressing a receptor specific for 
the self-antigen C51  (the fifth component of mouse com- 
plement) (19).  Contact ofT cells from C5 TCR-transgenic 
mice with C5 protein or C5 peptide in vivo or in vitro in- 
duces biased Thl-type responses resulting in exclusive pro- 
duction  of IL-2 and high levels of IFN-'y. In contrast  to 
nontransgenic littermates, which generate C5-specific anti- 
bodies, C5 TCtk-transgenic mice do not develop an anti- 
body response to C5. We used these transgenic mice to in- 
vestigate the role of APC in the determination of CD4 + T 
cell effector type. 
In this article we show that T  cell help for B cells and the 
induction  of IL-4 production  are  induced  by activated B 
cells  presenting  C5.  Under  physiological  conditions  in 
vivo, C5 may be preferentially presented by dendritic cells 
and  macrophages, resulting  in  skewing to  the  Thl  path- 
way.  Increasing B  cell  presentation in vitro and targeting 
C5 for B  cell presentation in adoptive transfer experiments 
in vivo induces the production  of IL-4 and generation of 
C5-specific antibodies. 
Materials and Methods 
Animals.  A/J  (C5-)  mice  are  maintained  under  specified 
pathogen-free conditions  at the  National  Institute  for Medical 
Kesearch,  Mill Hill. The congenic  strain A.C5 + was kindly pro- 
vided by Dr. F. Gervais (Montreal General Hospital Research In- 
stitute, Montreal,  Canada) (20) and is now bred in Mill Hill. The 
generation  of TCR-transgenic mice carrying a TCR specific for 
C5 was described in detail (19). 
1Abbreviations used in  this paper: C5,  fifth component of complement; 
MACS, magnetic cell sorting. 
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iments:  anti-IL-4  (11Bll  ATCC  HB  188),  anti-IL-2  ($4B6 
[21]), anti--CD8-FITC labeled, anti-CD4-PE labeled (Boehringer 
Mannheim  Corp.,  Indianapolis, IN),  anti-IFN-% 1K46A2 (22), 
and AN-18 (23).  Two antibodies to mouse CD40 were used in 
this study: FGK-45, a rat IgG/tr  made and generously provided 
by Drs. J. Andersson and A. 1Kolink (Basel Institute for Immunol- 
ogy, Basel,  Switzerland), and DOM1-85,  a  rat IgG/K made in 
our own laboratory (D. Gray). Both antibodies were raised by im- 
munizing rats with alum-precipitated CD40-human IgG1 soluble 
fusion protein. Positive clones reacted with the fusion protein but 
not  human  IgG1  in  ELISA; the  antibodies have  the  expected 
staining patterns on cell suspensions on the FACS  |  stimulate B 
cells to undergo homotypic adhesion and proliferation, do not bind 
to cells from CD40 knockout mice, and detect a 50-kD band in 
Western blots of B cell lysates. 
APC.  LK35 lymphoma/hybridoma cells (ATCC 98; Ameri- 
can Type Culture Collection [ATCC], Rockville, MD) were used 
as a source of B  cells.  For optimal expression of B7  molecules, 
LK35 were cultured in the presence of 20 ~g/ml LPS (Escherichia 
coli; L-2880; Sigma Chemical Co., St. Louis, MO) for 24 h before 
functional set ups.  97.2,  a  macrophage line derived from bone 
marrow of AKIK mice, was a gift from Dr.  1k.  Palacios (M.D. 
Anderson Cancer Center, Houston, TX). Macrophages were ac- 
tivated for MHC class II expression by culture with 200 U/ml re- 
combinant IFN-~/(derived from a cell line transfected with IFN-~/ 
eDNA (24) 48 h  before fi.mctional tests. Dendritic cells were de- 
rived from bone marrow cultures in the presence of GM-CSF as 
described in detail (25). The source of GM-CSF was supematant 
from HAT-sensitive Ag8653 myeloma cells transfected with mu- 
rine GM-CSF eDNA, which was isolated from a T  cell clone by 
PCIK and inserted into the vector BCMGSNeo, kindly provided 
by Dr. H. Karasuyama (Basel Institute for Immunology) (24). 
Functional T Cell Activation Tests.  B cells and macrophages, pre- 
treated as described above, were treated with mitomycin C  (50 
Ixg/ml; M-0503; Sigma Chemical Co.), plated into 96-well round- 
bottom tissue culture plates (at 5  ￿  104  cells/well or 103 cells/ 
well for dendritic cells) and incubated in the presence of C5 pep- 
tide 106-121  in serum-free medium for 3 h at 37~  Peptide was 
washed  out,  and  5  X  105  cells/well of transgenic  thymocytes 
were added as a source of naive T cells. The culture medium was 
IMDM supplemented with 5% heat-inactivated FCS, 2 X  10 -3 M 
L-glutamine, 100 U/ml penicillin, 100  lag/ml streptomycin, and 
5 X 10 -5 M ME. Supernatant from cultures incubated for 48 h was 
tested for the presence of IL-2 or IL-4, respectively, by its ability 
to  support the  growth  of the  IL-2-dependent cell line  CTLL 
(ATCC  TIB  214)  or the  IL-4-dependent cell line CT4S  (26). 
Residual activity of CT4S cells against IL-2 was blocked by addi- 
tion ofanti-IL-2 antibody $4B6. Supernatant from cultures incu- 
bated for 72 h was tested for IFN-~/activity by a sandwich ELISA 
as previously described (27).  Briefly, antibodies to mouse IFN-',/ 
were used for coating of ELISA plates, followed by addition of 
supernatants to be tested for the presence of IFN-% capture by a 
second biotinylated IFN-~/-specific antibody, and detection with 
streptavidin conjugated with horseradish peroxidase. 
Immunization and Determination of Antibody  Titers.  Mice  were 
immunized with 10 H,g alum-precipitated protein subcutaneously 
above the footpads. For determination of antibody titers, microti- 
ter ELISA plates  (Dynatech  Laboratories, Inc.,  Chantilly, VA) 
were coated with the test antigen at 10 Izg/ml; 50 ~,l/well in car- 
bonate/bicarbonate buffer, pH 9.5. Antibody titers were worked 
out by setting up doubling dilutions of serum, starting at 1 in 20. 
Curves  of absorbance (at  405  nm)  against serum dilution were 
plotted. The antibody titer was calculated as the reciprocal of the 
dilution that gave an absorbance of 30% of the maximum absor- 
bance reading for that particular assay. The maximum was given 
by a standard hyperimmune serum.  Secondary antiisotype anti- 
bodies used  in  these  assays were  the  following: alkaline phos- 
phatase  conjugates of goat  anti-mouse  IgG1,  goat  anti-mouse 
IgG2a, and goat anti-mouse IgM (all purchased from Southern 
Biotechnology Associates, Birmingham, AL). 
Sorting of Thymocytes.  Transgenic thymocytes were double la- 
beled with anti-CD8-FITC and anti-CD4-PE (Boehringer Mann- 
helm Corp.) and sorted for single CD4 + cells and double-positive 
cells using a FacsStar|  (Becton Dickinson & Co., Mountain 
View, CA) equipped with a laser working at 488 nm. 
Magnetic Cell Sorting (MACS) Preparation of B Cells.  Positive se- 
lection of B  cells from spleens of CBA nude mice was done by 
MACS with the Vario-MACS (Miltenyi Biotech, Bergisch Glad- 
bach,  Germany) using goat anti-rat Ig beads and following the 
procedure recommended in the manual. Positively selected cells 
were passed over the selection column twice, and the purity of 
the selected population was between 80 and 90%. 
Results 
C5 TCR-transgenic Mice Generate  Biased Th I  Responses  to 
C5.  Spleen cells from C5 TCIK-transgenic mice on a C5- 
(A/J) background stimulated in vitro with either C5  pro- 
tein  or  C5  peptide  generate  strong  IL-2  and  IFN-~/  re- 
sponses.  Spleen cells from nontransgenic A/J mice do not 
make primary in vitro responses to C5 (Fig. 1 A). Immuni- 
zation with  C5  protein resulted in  C5-specific  IgG  anti- 
body production in  nontransgenic  mice but  not  in trans- 
genic mice, which make IgM antibodies, but no switched 
isotypes (Fig. 1 B). The isotype of C5-specific antibodies in 
normal  mice  was  exclusively IgGl:  there  was  no  IgG2a 
produced and very little IgG2b (not shown).  This pheno- 
type was observed regardless of the mode of immunization; 
that is, C5 precipitated with alum injected with or without 
pertussis toxin intraperitoneally or subcutaneously, or C5 in 
CFA  injected  subcutaneously,  resulted  in  IgG1  antibody 
formation in nontransgenic  but not  transgenic C5-  mice. 
This indicates that contact with C5 in vivo and in vitro in- 
duces a  preferential Thl  response  in  the  transgenic  mice. 
Cytokine  effects  due  to  differences  in  the  genetic  back- 
ground are not likely to play a role in preferential differen- 
tiation to the Thl effector class since nontransgenic littermates 
readily made C5-specific antibodies of the Th2-dependent 
IgGt isotype. We therefore decided to investigate the role 
of different APC in influencing effector class development. 
Naive Resting  Transgenic  T  Cells  Develop into  Th I  Effector 
Cells  upon  Contact with Antigen  Presented  by Dendritic  Cells. 
As  a  source  of naive  transgenic  T  cells, we  used thymo- 
cytes.  Functional  activity resides  exclusively in  the  CD4 
single-positive subpopulation,  which  constitutes  ~8%  of 
total thymocytes. Fig. 2 shows that sorted CD4 single-pos- 
itive thymocytes generated IL-2 and IFN-~/in response to 
C5  presented by dendritic cells. No  IL-4 production was 
detectable. The sorted double-positive thymocyte popula- 
tion was not activatable at any cell dose used.  For the ex- 
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Figure  1.  (,4) Spleen cells from  A18.A 
transgenic mice  (squares) or nontramgenic 
A/J mice (circles) were cultured at 2 ￿  10  s 
cells/well with C5 protein. 48 h later they 
were  assessed for  production  of IL-2  by 
transfer of supematant to the IL-2-depen- 
dent CTLL line nad 72 h later for produc- 
tion of 1FN-~ by ELISA. The upper panel 
shows [3H]thymidine  incorporated into IL-2- 
dependent  CTLL  cells; the  lower  panel 
shows arbitrary values of OD at 414 nm as 
assessment of IFN-~/bound to ELISA plates. 
(/3) A18.A transgenic mice (squares) or non- 
transgenic A/J  mice  (drdes) were  immu- 
nized  with  10  I~g  alum-precipitated  C5 
protein  subcutaneously. At  different time 
points after immunization, mice were bled 
and assessed for production  of CS-specific 
antibodies oflgM, lgG1, and IgG2a subclass 
by ELISA. The graph shows antibody titers 
of  four mice per group. 
periments shown from now on, total unsorted thymocytes 
were used as a source of naive T  cells. 
Cytokine  Profiles Are Influenced by Different APC.  To  test 
the  effect of different APC  on  cytokine profiles, we used 
APC cell fines to avoid problems with purification and the 
inevitability of contamination. LK35 lymphoma/hybridoma 
cells activated by LPS for optimal expression of costimula- 
tory molecules were used as a source of activated B  cells. In 
addition,  we  used  the  macrophage  line 97.2  activated by 
IFN-~/  and  dendritic  cells  generated  from  bone  marrow 
cultures in the presence of GM-CSF. APC pulsed with C5 
peptide in  a  range from  10  txM  to  10  nM  were  cultured 
with transgenic thymocytes for either 48 h  (optimal release 
oflL-2 and IL-4) or 72 h  (optimal release oflFN-~/). Fig. 3 
A  shows IL-2, IL-4, and IFN-~/release by thymocytes cul- 
tured in the presence of either B  cells, macrophages,  or a 
very low number of dendritic cells. B  cells and macrophages 
alone stimulated low IL-2 responses, but no IFN-~/or IL-4 
response. 10  3 dendritic cells on their own activated naive T 
cells for IL-2 and IFN-~/production. The !FN-~/responses 
were variable and often much higher than in this experiment, 
but no IL-4 responses were observed in any experiment. Since 
dendritic  cells  are  essential  to  initiate  optimal  responses 
from naive T  cells, we  supplemented B  cells and macro- 
phages with 10  3 (2% of total APC) of dendritic cells. Macro- 
phages supplemented with  dendritic cells stimulated strong 
IL-2 and IFN-~/responses, but no IL-4 production was de- 
tectable (Fig. 3  B).  In contrast, B  cells supplemented with 
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Figure  2.  Thymocytes from A18.A  trans- 
genie mice were sorted by FACStar  |  for CD4 
single-positive cells (squares)  or CD4+8 + dou- 
ble-positive cells (circles).  10  s sorted cells/well 
were cultured in the presence of 2  ￿  104 den- 
dritic cells (from bone marrow cultures with 
GM-CSF) and various doses of either C5 pro- 
tein  (solid  lines)  or  C5  peptide  (dashed  lines). 
After 48 h, supernatants were assessed for the 
presence of IL-2, and after 72 h, for the pres- 
ence of IFN-~/. 
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Figure 3.  (A) 5 ￿  10  s unseparated thymocytes per well from A18.A transgenic mice were cultured for 48 h  (IL-2 and IL-4 assessment) or 72 h (IFN-T 
assessment) in the presence of different peptide-pulsed APC. These were either LK35 B cells (squares;  5  ￿  104 cells/well) pretreated with LPS (20 ~g/ml) 
for 24 h before the assay, 97.2 macrophages (circles; 5  ￿  104 cells/well) pretreated for 48 h before the assay with 200 U/ml recombinant IFN-% or den- 
dritic cells (triangles;  10  3 cells/well) from bone marrow cultures. B cells and macrophages were treated with mitomycin C, and all APC were pulsed with 
the indicated doses of peptide in serum-free medium for 3 h at 37~  Peptide was washed out of the cultures extensively before addition ofT cells. IL-2 
production was assessed by proliferation of IL-2-dependent CTLL cells,  IL-4 production was assessed on IL-4-dependent CT4S cells in the presence of 
anti-IL-2 antibody, and IFN-~/was assessed  by ELISA. (B) B cells and macrophages were mixed with 2% dendritic cells (103/well), and the experimental 
set up was otherwise identical to that described in A. The squares with dashed lines in the IL-4 panel represent the IL-4 response induced by B cells plus 
2% dendritic cells in the presence ofanti-IL-4 antibody (10 ~g/ml 11B11). 
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Figure 4.  IL-4 production induced by normal B cells. 5  ￿  10  s unsepa- 
rated  thymocytes per  well  from A18.A  transgenic mice were  cultured 
with 5  ￿  104 B  cells per well positively selected from spleens of CBA 
nude mice by MACS.  Open  symbols represent the  IL-4  response ob- 
tained after culture with fleshly isolated B  cells, and sohd symbols repre- 
sent the response induced by B cells activated for 24 h by LPS (20 Ixg/ml). 
dendritic cells stimulated not only release of IL-2, but also 
IL-4.  The  IL-4 release was  abrogated  in  the  presence  of 
anti-IL-4 antibody. Interestingly, the IFN-~/responses nor- 
really detected with dendritic cells on their own were sup- 
pressed in  the  presence  of B  cells.  IL-4 responses  in  the 
presence orB cells were detected in four out of six experi- 
ments. In the two experiments that did not show IL-4 re- 
lease by transgenic T  cells,  IF￿  was detected instead, in- 
dicating a delicate balance in the switch to either Thl- or 
Th2-type cytokines. These results show that APC influence 
the cytokine profile of CD4 T  cells and indicate that B cell 
presentation is essential for a switch to IL-4 production. 
Presentation by Normal B Cells  Induces Th2 Responses.  The use 
of cell hnes as APC was justified to avoid problems of cross- 
contamination and heterogeneity of  APC preparations. How- 
ever, we were concerned about the possibility that the B 
cell tumor line might itself produce  Th2-inducing factors 
and  therefore not resemble normal B  cells.  Therefore we 
repeated the  experiments with t3  cells  purified from mice 
by positive selection with MACS beads. Freshly isolated B 
cells pulsed with peptide in vitro did not induce IL-4-pro- 
ducing T  cells,  but B  cells activated by LPS for 24 h  initi- 
ated  a  strong IL-4 response comparable to  that seen after 
stimulation with the B cell line (Fig. 4). 
Anti-CD40 Antibodies Suppress Generation of IL-4 Responses. 
To investigate which cell surface molecules are involved in 
the interaction between B  cells  and  T  cells  to promote a 
switch to  IL-4, antibody-blocking studies  with antibodies 
to  CD4,  B7,  and  CD40  were carried  out.  Whereas  anti- 
CD4 and anti-B7 antibodies decreased or abrogated all cy- 
tokine responses  (data not shown),  anti-CD40  had a very 
discriminatory  effect.  As  shown  in  Fig.  5,  two  different 
anti-CD40 antibodies suppressed the production of IL-4 in 
the presence of B cells, and instead provoked an IFN-~/re- 
sponse. We conclude that an interaction betwee CD40 ex- 
pressed on B  cells and CD40 ligand on T  cells is necessary 
to signal a switch to IL-4 production. 
B Cell Presentation In  Vivo Is Critical  for the Development of 
Th Cells.  Given that B  cells  appear to play a crucial role 
in determining the developmental pathway ofCD4 T  cells, 
as indicated by cytokine release in vitro, a crucial question 
was whether  they play this  role in vivo.  Since  our trans- 
genic mice do not develop antibodies to C5, the underlying 
assumption is  that presentation  by macrophages and den- 
dritic  cells  overrides B  cell presentation and skews effector 
cell development into the Thl lineage.  To target antigen pref- 
erentially to B cells, we used a hapten carrier adoptive trans- 
fer system. For this, we used DNP-specific B  cells that in- 
ternalized haptenated DNP-C5 and subsequently processed 
C5 peptides for presentation to transgenic T cells. Two groups 
oftransgenic mice were immunized as shown in the scheme 
in Fig. 6. Group I received 106 bone marrow-derived den- 
dritic cells that had been pulsed with C5 protein and were 
coinjected with soluble haptenated DNP-C5.  Group II re- 
ceived 10  ￿  106 DNP-immune B  cells purified from C5 + 
mice immunized with DNP on ovalbumin as carrier pro- 
tein. It should be pointed out that these donor mice, which 
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Figure  5.  5  ￿  10  s  unseparated  thy- 
mocytes per well from A18.A transgenic 
mice were cultured with a mixture ofmi- 
tomycin-treated  LK35  cells  (5  ￿  104/ 
well)  and  dendritic  cells  (103/well)  that 
were  pulsed  together  with  the  peptide 
doses  indicated  on  the  abscissa,  in  the 
same manner as described in the legend to 
Fig.  3.  IL-4 and IFN-~/ production were 
assessed in the absence (solid squares,  solid 
lines)  or presence of 20 ~g/ml anti-CD40 
antibodies.  (Open  squares,  solid lines  anti- 
CD40 antibody FGK-45, and open squares, 
dashed lines anti-CD40 antibody DOM1- 
85).  IL-4  production  was  assessed after 
48 h  of culture,  and  IFN-~I  was assessed 
after 72 h. I  Group I  J 
10  6 C5-pulsed 
dendritic  ceils 
§ 
lol~g DNP-C5 
Bleed days: 
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Immunization scheme. Priming oftransgenic T cells in the presence of specific  B cells allows anti-C5 antibody responses. 
have C5 in their circulation, contain neither C5-specific T 
cells nor C5-specific B  cells since they are tolerant of their 
own C5. In addition to the B  cells, 106 C5-pulsed dendritic 
cells as in Group I were included to optimize activation of 
naive T  cells in the adoptive host: thus,  Group II mice re- 
ceived B  cells,  dendritic  cells,  and  soluble  DNP-C5.  At 
various times after injection, the mice were bled and tested 
for  IgG1  and  IgG2a  antibody  production  against  DNP- 
BSA or C5. Some mice were boosted with soluble uncon- 
jugated C5  at day  14  after transfer.  The  results shown  in 
Fig. 7 provide evidence that antigen targeting to B  cells al- 
lows the development of helper T  cells supporting an anti- 
body  response.  Group  II  mice  made  antibodies  against 
DNP  of IgG1 and IgG2a subclass, which were presumably 
derived  from  the  donor  inoculum  of DNP-immune  B 
cells.  It should be  stressed that  DNP  immune  B  cells are 
dependent on T  cell help for reactivation to antibody pro- 
duction. This was verified by injecting them into C5 + mice 
together with  DNP-C5,  where  they failed to  make  anti- 
DNP  antibodies because  of the absence  of carrier-specific 
helper T  cells (data not shown), More importantly, in addi- 
tion to DNP  antibodies, Group II mice generated C5-spe- 
cific antibodies, which could only have been derived from 
the  endogenous  B  cell population in  the  transgenic  host. 
Boosting with  soluble C5  further  increased this  response. 
In contrast, none  of the Group I  mice made any antibody 
responses despite the fact that injection with antigen-pulsed 
dendritic cells results in strong T  cell activation (data not 
shown).  Interestingly,  CS-specific  antibodies  detected  in 
Group II transgenic mice consisted of both IgG1 as well as 
IgG2, whereas in normal mice the IgG1 response predomi- 
nates and IgG2a is never detected (see Fig. 1 B). 
3OO 
loo- 
tgG1 antl-DNP 
200 
loo-I 
IgG2a anti-DNP 
x  O- 
II 
5  9  14  20  5  9  14  20 
Days after transfer 
Figure 7.  Two groups ofA18.A transgenic mice (four mice per group) 
were injected as illustrated in the scheme in Fig. 5. One group received 
106 dendritic cells that had been pulsed with 10/~g/ml C5 protein for 6 h 
before injection, washed, and coinjected intravenously with 10 I~g DNP- 
C5 in PBS. The second group received a mixture of C5-pulsed dendritic 
cells and 10 ￿  106 MACS-purified B cells from congenic A.C5 + donors 
primed 3 wk previously with DNP-ovalbumin. The cells  were coinjected 
intravenously with 10 I~g soluble DNP-C5. At different time points after 
injection, the mice were bled and assessed  for IgG1 and IgG2a antibodies 
specific for DNP  or C5.  Antibody titers of four  mice per group  are 
shown. [3, Group I (DC only); IB, Group II (DC + B). 
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It was shown several years ago that the basis of cognate T 
cell  help  for B  cells  resides in  antigen  presentation  by B 
cells and the subsequent display of class II-bound peptides 
recognized by specific T  cells so that cytokine release is tar- 
geted  to  antigen-specific  B  cells  (28).  In  this  article  we 
show that the influence of B  cell presentation to T  cells is 
even more pervasive as it directly influences the differentia- 
tion ofT cells into Th2 helper cells. 
A number of studies have analyzed stimulation of differ- 
ent CD4 effector cells by various APC (29, 30), or the role 
of APC in initiation of Thl or Th2 development from na- 
ive T  cells (7, 8, 31-33). With the exception of the clearcut 
influence ofmacrophages on Thl differentiation, there was 
no obvious correlation between a particular type of APC 
and the  development of either effector class, and a candi- 
date  APC  for promotion  of Th2  responses  has not  been 
identified so far. What seems clear is that under certain cy- 
tokine conditions, that is, in the presence oflL-4, any APC 
will stimulate a Th2 response (7, 31, 34). The crucial point 
of our study is that in the absence of a favorable cytokine 
environment, presentation of antigen by B  cells can over- 
ride stimuli that otherwise will skew development to Thl 
phenotype. What are these stimuh? It has been pointed out 
that the hgand density avaiable for T  cell recognition plays 
an important role, with high hgand density favoring differ- 
entiation of Thl  cells and low hgand density favoring dif- 
ferentiation of Th2 cells (16).  It seems likely that the effec- 
tive hgand density on different APC varies, depending on 
the way they take up antigen. Thus, hgand density may de- 
pend on the nature of the antigen and which APC prefer- 
entially or initially presents it. Although there is no infor- 
marion available about the actual ligand densities created for 
complex proteins like  C5  on different APC,  we do have 
evidence  that  it  is  handled  quite  differently  by  different 
APC (35). 
C5 is very efficiently presented by dendritic cells and also 
by macrophages, both of which have been shown to pro- 
duce IL-12, which drives development of Thl  cells  (4,  5). 
In fact, we know that under physiological conditions, den- 
dritic  cells  presenting C5  are the only APC that can acti- 
vate resting T  cells  (36).  A caveat is that we have no infor- 
marion  about  antigen-specific  B  cells,  which  in  other 
systems have been shown to be capable of activating resting 
T  cells (37).  Our in vitro data show that B cell presentation 
can result in a switch to Th2 mode.  The B  cells  used for 
these experiments were artificially turned into antigen-spe- 
cific B  cells  expressing costimulatory molecules and  high 
amounts ofpeptide on class II. Whether this accurately re- 
flects  truly  antigen-specific  B  cells  in  vivo  is  debatable. 
However, it was evident that switching to Th2 responses 
was achieved whether the source of  B cells was a tumor cell 
hne or normal B  cells  isolated directly from mice. The in 
vitro  studies  suggest  that  some  dendritic  cells  had  to  be 
present to initiate a T  cell response in the first place. How- 
ever, when dendritic cells are overrepresented, a switch to 
Thl development was inevitable. 
A  limited  analysis  of the  molecular basis  of this  Th2- 
inducing  activity  of B  cells  revealed  that  blocking  the 
CD40-CD40  hgand interaction with anti-CD40  antibod- 
ies inhibited the release of IL-4, but not IL-2 and IFN-~/, 
whereas B7 blockade impaired all cytokine release. The in- 
terpretation we favor is that costimulatory signals  to T  cells 
delivered via CD40 ligand are responsible for Th2 induc- 
tion. This is in line with the observation that T  cells primed 
in CD40 knockout mice do not develop fiall helper func- 
tion; they do not support IgG responses of normal (CD40 +) 
B cells (37). 
This brings up an issue that at first sight may seem para- 
doxical. Why is the interaction of CD40  on B  cells  with 
CD40 ligand on T  cells involved in a switch to Th2 when 
dendritic cells constitutively express CD40 themselves? The 
answer to this question must be twofold. First, at the time 
when the first interaction of a dendritic cell with a naive T 
cell occurs, this T  cell does not yet express CD40 hgand. 
The capacity of dendritic cells to initially activate a resting 
T  cell  is  therefore  independent  of a  CD40  interaction. 
Once the T  cell does express CD40 ligand, subsequent in- 
teractions involving CD40 on dendritic cells will neverthe- 
less not induce a Th2 switch, but rather the opposite, since 
dendritic cells are potent producers of IL-12 (4). Although 
IL-12  cDNA  was  originally  isolated  from  EBV-trans- 
formed B cells (38),  and murine B cell lines are reported to 
produce IL-12 (39),  the conditions under which normal B 
cells secrete this cytokine, if at all, are far from clear (40). 
Nontransgenic C5- mice make very strong antibody re- 
sponses to C5 dominated by a Th2-dependent isotype, yet 
their transgenic httermates respond with a default reaction 
to Thl phenotype, precluding an antibody response. What 
is the underlying mechanism for this? We have no final an- 
swer to this at present, but propose that the phenomenon is 
due to a gross imbalance in the frequencies of antigen-spe- 
cific T  cells compared with antigen-specific B  cells.  Den- 
dritic cells capable of presenting C5 are more frequent than 
antigen-specific B cells, so that their chances to encounter a 
C5-specific T  cell are increased. This will result in a strong 
bias  to  Thl  development,  which,  through  the  release  of 
IL-12 and IFN-% will negatively influence Th2 differenti- 
ation of those T  cells that have been presented with antigen 
by B  cells. The fact that there is an IgM antibody response 
indicates  that  there  is  help produced.  The  developmental 
state of T  cells providing help for IgM is not known, but it 
is  CD40  independent  (41,  42)  and may be  Th0.  Recent 
data (43)  have suggested that Th2 development might re- 
quire  repeated  signaling  over  a  short  time  period.  This 
could mean in our system that it takes a certain number of 
B-T interactions to sustain a switch to Th2, a situation that 
is  guaranteed  in  the  in  vitro  set  up  and  in  the  adoptive 
transfer situation,  but not under normal conditions  in the 
transgenic host. 
An interesting point worth mentioning is the  develop- 
ment of IgG2a antibodies in the adoptive transfer studies in 
which presentation was targeted to B  cells.  The switch to 
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genic mice, which generate IFN-~/in response to antigen, 
no  IgG2a  antibody  response  is  observed  until  Th2  re- 
sponses  are  present.  There  is  an  observation  that  the  in 
vitro IFN-~/-mediated IgG2a antibody response is depen- 
dent on  the presence  of Th2-type cytokines such  as IL-5 
(46), and our data in the transgenic system support this sug- 
gestion. 
Taken  together,  our  data suggest  that  the  B  cell is  the 
crucial APC for the development of Th2 responses. A  cru- 
cial molecule involved in this process is CD40  on the sur- 
face of B  cells. Whether this is sufficient or whether there 
are additional signals from other cell surface molecules in- 
volved remains to be determined. The  demonstration that 
B  cell presentation can override an intrinsic propensity for 
Thl development in this system opens the possibility to de- 
liberately manipulate immune responses for the desired ef- 
fector class. A very recent example of this is the finding that 
targeting of myelin basic protein to B  cells abrogates induc- 
tion of experimental allergic encephalomyelitis and results 
in switching to IL-4 secretion (47). 
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